Taysha Gene Therapies, Inc.

This study is testing a single injection of an experimental gene therapy called TSHA-102 for girls aged 5 to 8 with Rett syndrome. The main goal is to see if the treatment is safe and well-tolerated at two different dose levels. Researchers will also look for early signs that it …